8-K: Nukkleus Inc. Secures $10 Million Standby Equity Facility with YA II PN, LTD

Nukkleus Inc. has entered into a standby equity purchase agreement with YA II PN, LTD., providing the company with access to up to $10 million in funding through the sale of common stock.

Summary

• Nukkleus Inc. has established a Standby Equity Purchase Agreement (SEPA) with YA II PN, LTD., allowing the company to sell up to $10 million of its common stock.
• The agreement includes a $2 million pre-paid advance to Nukkleus in the form of convertible promissory notes, disbursed in three tranches.
• The first tranche of $500,000 was received on December 3, 2024, with subsequent tranches of $250,000 and $1,250,000 contingent on SEC filings and shareholder approval.
• Nukkleus has the option to sell shares to the investor at 97% of the lowest daily volume-weighted average price (VWAP) during a three-day pricing period.
• The investor also has the right to initiate purchases by converting the promissory notes into shares at a conversion price based on the lower of $2.00 or 90% of the lowest VWAP during the ten trading days prior to conversion, with a floor price of $0.33.
• The agreement includes a commitment fee of $300,000 payable in three tranches and a $25,000 structuring fee.
• The SEPA will terminate on the earlier of January 1, 2027, or when the investor has purchased $10 million of common stock.

Sentiment

Score: 4

Explanation: While the agreement provides needed capital, the terms are unfavorable to existing shareholders due to potential dilution and the investor's ability to initiate share purchases. The floor price and conversion terms suggest a lack of confidence in the company's stock price.

Positives

• The agreement provides Nukkleus with a flexible source of capital up to $10 million.
• The pre-paid advance of $2 million provides immediate funding.
• The company has the option, but not the obligation, to sell shares to the investor.
• The agreement allows the company to control the timing and amount of share sales, except for investor-initiated conversions.
• The company can terminate the agreement with five trading days' notice if certain conditions are met.

Negatives

• The investor has the right to initiate purchases by converting promissory notes into shares.
• The conversion price of the promissory notes can be significantly lower than the fixed price of $2.00.
• The agreement includes a commitment fee of $300,000 and a $25,000 structuring fee.
• The agreement could lead to significant dilution of existing shareholders if the full $10 million is utilized.
• The investor has the right to cause an advance notice to be deemed delivered to the investor and the issuance and sale of shares to the investor pursuant to an advance.

Risks

• The company's ability to access the full $10 million is contingent on market conditions and the company's stock price.
• The conversion of promissory notes could lead to significant dilution of existing shareholders.
• The investor has the right to cause an advance notice to be deemed delivered to the investor and the issuance and sale of shares to the investor pursuant to an advance.
• The company may be required to make monthly payments to the investor if certain events occur, such as the stock price falling below the floor price or the company issuing more than 99% of the shares available under the exchange cap.
• The company's stock price could be negatively impacted by the issuance of new shares under the agreement.

Future Outlook

The company expects that any proceeds received from sales to the investor will be used for working capital and general corporate purposes. The actual sales of shares will depend on a variety of factors to be determined by the company from time to time, which may include, among other things, market conditions, the trading price of the company's common stock and determinations by the company as to the appropriate sources of funding for its business and operations.

Management Comments

• The company will control the timing and amount of any sales of shares of common stock to the investor, except with respect to investor advances.

Industry Context

This type of financing agreement is common for companies seeking flexible access to capital, particularly those with volatile stock prices or limited access to traditional financing. The use of a standby equity purchase agreement allows the company to draw down funds as needed, while also providing the investor with the potential for profit through share purchases and conversions.

Comparison to Industry Standards

• The terms of this agreement, including the discount to VWAP, the conversion price, and the commitment fee, are generally consistent with industry standards for standby equity purchase agreements.
• Similar agreements often include a pre-paid advance, which is also present in this case.
• The ownership limitation of 4.99% is a common provision to prevent the investor from becoming a controlling shareholder without triggering additional regulatory requirements.
• The inclusion of a floor price in the conversion terms is also a common feature to protect the company from excessive dilution.
• The amortization event triggers are also common in these types of agreements to protect the investor from a declining stock price or other adverse events.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Employees may benefit from the company's increased financial stability.
• Customers and suppliers may see improved business continuity due to the company's access to capital.
• Creditors may have increased confidence in the company's ability to meet its obligations.

Next Steps

• The company needs to file a registration statement with the SEC.
• The company needs to obtain shareholder approval to issue shares in excess of 19.99% of outstanding shares.
• The company will need to manage the timing and amount of share sales to the investor.
• The company will need to monitor the stock price and trading volume to determine the optimal time to sell shares.

Key Dates

Keywords

standby equity purchase agreement, common stock, convertible promissory notes, equity financing, YA II PN, LTD, Nukkleus Inc., dilution, VWAP, pre-paid advance, registration rights